Cytokeratin 18 antibody
Quick Overview for Cytokeratin 18 antibody (ABIN965968)
Target
See all Cytokeratin 18 (KRT18) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- Concentrated.
-
Immunogen
- PMC-42 Human Breast Carcinoma Cells
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
Immunohistochemistry: (Paraffin/Frozen).
Staining Procedure: When using paraffin-embedded and formalin-fixed tissues, predigestion with AutoZyme or high temperature antigenic unmasking technique is strongly recommended for consistent and reproducible results. The optimal conditions should be determined by the individual laboratory. The antibody may be used at a dilution of 1:50 to 1:100 with AutoProbe III. -
Comment
-
Cellular Localization: Cytoplasmic.
Recommended Positive Control: Colon Carcinoma -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.3 mg / ml.
-
Buffer
- 20 mM Tris-Borate, 150 mM Sodium Chloride, dialyzed media RPMI 1640/D-MEM containing Fetal Bovine Serum, BMC-6 Carrier Polysaccharides, Carrier Protein, pH 7.5
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
-
- Cytokeratin 18 (KRT18) (Keratin 18 (KRT18))
-
Alternative Name
- Cytokeratin18 (45kDa)
-
Background
- This antibody reacts with Cytokeratin 18 (45 kD) polypeptide and with a wide variety of simple epithelia. It does not react with stratified squamous epithelia. It reacts with epithelial tumors of the gastrointestinal tract, lung, breast, pancreas, ovary, and thyroid.
-
Gene ID
- 3875
-
Pathways
- Apoptosis, Caspase Cascade in Apoptosis
Target
-